Art Plus Technology

Art Plus Technology (APT) is a South Korean medical device company specializing in the research, development, and manufacturing of interventional cardiology and vascular products. Founded in 2002, the company is best known for its advanced coronary stent systems, including bare-metal and drug-eluting stents designed to treat coronary artery disease. APT leverages proprietary coating technologies and precision engineering to produce high-quality catheters and stents that aim to improve clinical outcomes and reduce restenosis. Their flagship Aptos product line is widely used in cardiovascular procedures across Asia and international markets. The company maintains a strong focus on biocompatibility and the deliverability of vascular implants through continuous R&D.